Publications by authors named "Nathan Levitan"

Claim this Profile
P
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy.
Frances A Shepherd, Janet Dancey, Rodryg Ramlau, Karin Mattson, Richard Gralla, Nathan Levitan

J Clin Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality and cost outcomes of an integrated supportive care program.
Elizabeth Weinstein, Matthew Kemmann, Sara L Douglas, Barbara Daly, Nathan Levitan

Support Care Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence in oncology: Path to implementation.
Isaac S Chua, Michal Gaziel-Yablowitz, Zfania T Korach, Kenneth L Kehl, Nathan A Levitan

Cancer Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcome performance measures in oncology.
Ethan Basch, Claire Snyder, Kristen McNiff, Rebecca Brown, Suzanne Maddux, Nathan Levitan

J Oncol Pract· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of paclitaxel + etoposide + cisplatin + concurrent radiation therapy for previously untreated limited stage small cell lung cancer (E2596): a trial of the Eastern Cooperative Oncology Group.
Leora Horn, Patricia Bernardo, Alan Sandler, Henry Wagner, Nathan Levitan

J Thorac Oncol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of thalidomide as maintenance therapy for extensive stage small cell lung cancer after response to chemotherapy.
Afshin Dowlati, Shanmuga Subbiah, Matthew Cooney, Kimberly Rutherford, Tarek Mekhail, Nathan Levitan

Lung Cancer· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Program report cards: evaluation across multiple residency programs at one institution.
Roy Phitayakorn, Nathan Levitan, Jerry M Shuck

Acad Med· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer.
Afshin Dowlati, Robert Chapman, Shanmuga Subbiah, Pingfu Fu, Anne Ness, Nathan Levitan

Invest New Drugs· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trial.
Francis W Nugent, Wilson C Mertens, Stephen Graziano, Nathan Levitan, Rufus Collea

Lung Cancer· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel for malignant mesothelioma: phase II study of the Eastern Cooperative Oncology Group.
Chandra P Belani, Sudeshna Adak, Seena Aisner, Philip J Stella, Nathan Levitan

Clin Lung Cancer· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular safety profile of combretastatin a4 phosphate in a single-dose phase I study in patients with advanced cancer.
Matthew M Cooney, Tomas Radivoyevitch, Afshin Dowlati, Beth Overmoyer, Nathan Levitan

Clin Cancer Res· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination chemotherapy with topotecan for non-small cell lung cancer.
Afshin Dowlati, Nathan Levitan

Lung Cancer· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy response in esophageal carcinoma.
Joseph Willis, Gregory S Cooper, Gerard Isenberg, Michael V Sivak, Nathan Levitan

Gastrointest Endosc· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis